Relationship between renal dysfunction and electrolyte abnormalities in hematopoietic stem cell transplant patients treated with foscarnet

References

• Boeckh M, Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev. 1998;11(3):533–54.
   PubMed Web of Science ®Google Scholar
• Ljungman P. Beta-herpesvirus challenges in the transplant recipient. J Infect Dis. 2002;186(s1):S99–s109.
   PubMedGoogle Scholar
• Winston DJ, Gale RP. Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s. Bone Marrow Transplant. 1991;8(1):7–11.
   PubMed Web of Science ®Google Scholar
• Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, Sato H, Watanabe T, Hosoya N, Izutsu K, et al. Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation. Int J Hematol. 2008;87(3):310–8.
   PubMed Web of Science ®Google Scholar
• Boeckh M, Leisenring W, Riddell SR, Bowden RA, Huang M-L, Myerson D, Stevens-Ayers T, Flowers MED, Cunningham T, Corey L, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood. 2003;101(2):407–14.
   PubMed Web of Science ®Google Scholar
• Einsele H, Hebart H, Kauffmann-Schneider C, Sinzger C, Jahn G, Bader P, Klingebiel T, Dietz K, Löffler J, Bokemeyer C, et al. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection. Bone Marrow Transplant. 2000;25(7):757–63.
   PubMed Web of Science ®Google Scholar
• Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. Biol Blood Marrow Transplant. 2003;9(9):543–58.
   PubMed Web of Science ®Google Scholar
• Ishiyama K, Katagiri T, Ohata K, Hosokawa K, Kondo Y, Yamazaki H, Takami A, Nakao S. Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation. Transpl Infect Dis. 2012;14(1):33–9.
   PubMed Web of Science ®Google Scholar
• Ljungman P, de la Camara R, Cordonnier C, Einsele H, Engelhard D, Reusser P, Styczynski J, Ward K, for the European Conference on Infections in Leukemia Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant. 2008;42(4):227–40.
   PubMed Web of Science ®Google Scholar
• Reusser P, Einsele H, Lee J, Volin L, Rovira M, Engelhard D, et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood. 2002;99(4):1159–64.
   PubMed Web of Science ®Google Scholar
• Stocchi R, Ward KN, Fanin R, Baccarani M, Apperley JF. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. Haematologica. 1999;84(1):71–9.
   PubMed Web of Science ®Google Scholar
• Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med. 1993;118(3):173–8.
   PubMed Web of Science ®Google Scholar
• Gearhart MO, Sorg TB. Foscarnet-induced severe hypomagnesemia and other electrolyte disorders. Ann Pharmacother. 1993;27(3):285–9.
   PubMed Web of Science ®Google Scholar
• Jacobson MA, Gambertoglio JG, Aweeka FT, Causey DM, Portale AA. Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. J Clin Endocrinol Metab. 1991;72(5):1130–5.
   PubMed Web of Science ®Google Scholar
• Beaufils H, Deray G, Katlama C, Dohin E, Henin D, Sazdovitch V, et al. Foscarnet and crystals in glomerular capillary lumens. Lancet. 1990;336(8717):755.
   PubMed Web of Science ®Google Scholar
• Ota R, Hirata A, Noto K, Yokoyama S, Hosomi K, Takada M, Matsuoka H. Relationship between serum calcium and creatinine in hematopoietic stem cell transplantation patients treated with foscarnet. CP. 2020;58(05):274–81.
   Google Scholar
• Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J. 1973;4(5893):643–6.
   PubMedGoogle Scholar
• Mizuno T, Sato W, Ishikawa K, Shinjo H, Miyagawa Y, Noda Y, Imai E, Yamada K. KDIGO (Kidney Disease: Improving Global Outcomes) criteria could be a useful outcome predictor of cisplatin-induced acute kidney injury. Oncology. 2012;82(6):354–9.
   PubMed Web of Science ®Google Scholar
• Rodrigues FB, Bruetto RG, Torres US, Otaviano AP, Zanetta DM, Burdmann EA. Incidence and mortality of acute kidney injury after myocardial infarction: a comparison between KDIGO and RIFLE criteria. PLoS One. 2013;8(7):e69998.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. 2017. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_50. Accessed 27, April, 2020.
   Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8.
   PubMed Web of Science ®Google Scholar
• Moore EW. Ionized calcium in normal serum, ultrafiltrates, and whole blood determined by ion-exchange electrodes. J Clin Invest. 1970;49(2):318–34.
   PubMedGoogle Scholar
• Castelli F, Tomasoni L, Zeroli C, Suter F, Trespi G, Carosi G, Hedman A. Comparison of pharmacokinetics and dynamics of two dosage regimens of foscarnet in AIDS patients with Cytomegalovirus retinitis. Eur J Clin Pharmacol. 1997;52(5):397–401.
   PubMed Web of Science ®Google Scholar
• Kos CH, Karaplis AC, Peng J-B, Hediger MA, Goltzman D, Mohammad KS, Guise TA, Pollak MR. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J Clin Invest. 2003;111(7):1021–8.
   PubMed Web of Science ®Google Scholar
• Tyler Miller R. Control of renal calcium, phosphate, electrolyte, and water excretion by the calcium-sensing receptor. Best Pract Res Clin Endocrinol Metab. 2013;27(3):345–58.
   PubMed Web of Science ®Google Scholar
• Lameris AL, Monnens LA, Bindels RJ, Hoenderop JG. Drug-induced alterations in Mg2+ homoeostasis. Clin Sci (Lond). 2012;123(1):1–14.
   PubMed Web of Science ®Google Scholar
• Stünzi H, Perrin DD. Stability constants of metal complexes of phosphonoacetic acid. J Inorg Biochem. 1979;10(4):309–16.
   Web of Science ®Google Scholar
• Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. JASN. 2007;18(10):2649–52.
   Web of Science ®Google Scholar
• Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. CJASN. 2015;10(7):1257–72.
   PubMed Web of Science ®Google Scholar
• Juan D. Differential diagnosis and mechanisms. Arch Intern Med. 1979;139(10):1166–71.
   PubMedGoogle Scholar
• Asakura M, Ikegame K, Yoshihara S, Taniguchi S, Mori T, Etoh T, Takami A, Yoshida T, Fukuda T, Hatanaka K, et al. Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. Int J Hematol. 2010;92(2):351–9.
   PubMed Web of Science ®Google Scholar